CEBP Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Skalkidou, A.
Right arrow Articles by Trichopoulos, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Skalkidou, A.
Right arrow Articles by Trichopoulos, D.
Cancer Epidemiology Biomarkers & Prevention Vol. 12, 860-865, September 2003
© 2003 American Association for Cancer Research

Determinants and Consequences of Major Insulin-like Growth Factor Components among Full-Term Healthy Neonates

Alkistis Skalkidou1, Eleni Petridou, Evgenia Papathoma, Heraklis Salvanos, Simos Kedikoglou, Georgios Chrousos and Dimitrios Trichopoulos

Department of Hygiene and Epidemiology, Athens University Medical School [A. S., E. P., S. K., D. T.] and First Department of Pediatrics, ‘Ag. Sofia’ Children’s Hospital [G. C.], Athens University Medical School, Athens; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115 [E. P., D. T.]; Department of Neonatology, ‘Alexandra’ Maternity Hospital, Athens [E. P.]; and Department of Neonatology, ‘Marika Iliadi’ Maternity Hospital, Athens, Greece [H. S.]

The purpose of this research was to investigate determinants of the insulin-like growth factor (IGF) system among healthy full-term newborns and explore their relation with anthropometric variables at birth. Components of the IGF system have been implicated in the pathogenesis of several forms of cancer, and perinatal events have been linked to chronic diseases in later life. Measurements of weight and length, as well as blood samples, were obtained from 331 healthy full-term newborns delivered during 1999 in Athens, Greece. Because the liver is important for IGF production, newborns were chosen to have bilirubin levels either <=8 mg/dl or >=12 mg/dl to operationally distinguish them according to the liver function. IGF-I, IGF-II, and IGF binding protein-3 were inversely associated with the presence of neonatal jaundice and blood creatinine, after controlling for blood protein levels. IGF-I increased rapidly and significantly over a period of a few days and was strongly positively associated with both birth weight and ponderal index. Newborn levels of IGF-I declined with maternal age. In comparison with first-born newborns, later-born ones had significantly higher blood IGF-I levels. We conclude that IGF-I plays a dominant role in growth during the perinatal period and that all three studied components of the IGF system are sensitive to liver and kidney function. These findings provide an insight into the processes involved in perinatal growth.




This article has been cited by other articles:


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
A. Maria Verner, J. Manderson, T. R J Lappin, D. R McCance, H. L Halliday, and D. G Sweet
Influence of maternal diabetes mellitus on fetal iron status
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2007; 92(5): F399 - F401.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
K. Pazaitou-Panayiotou, T. Kelesidis, I. Kelesidis, A. Kaprara, J. Blakeman, I. Vainas, A. Mpousoulegas, C. J Williams, and C. Mantzoros
Growth hormone-binding protein is directly and IGFBP-3 is inversely associated with risk of female breast cancer
Eur. J. Endocrinol., February 1, 2007; 156(2): 187 - 194.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2003 by the American Association for Cancer Research.